|
|
Post by mango on Jul 27, 2018 22:33:29 GMT -5
Actually, I find baseless bashing "very frustrating." When and where did management talk about having "some huge partner lined up?" Never happened. How about Torrey Pines? Tell me a bit about Receptor Life Sciences? That's enough for now. Let's feed the troll. One Drop and MannKind currently have an active clinical trial together with the estimated primary completion date set for September 30, 2018. The rest you can look up yourself. |
|
|
|
Post by patten1962 on Jul 27, 2018 22:40:49 GMT -5
What is really sad to me is the way shorts bash the company and could give 2 shits about a drug that really helps diabetics!
Listen, I wanna make money like the next person does but listening to Negative comments only because of money and never giving a shit about patient care is getting old.
Afrezza helps people.
This is #1.
Stock price will adjust soon enough.
God Bless you Mr. Mann!
|
|
|
|
Post by roguesuerte on Jul 27, 2018 22:48:40 GMT -5
Hugely disappointed by lack of transparency here. Tanners group game plan, RLS game plan, not to mention Trepostinil, Torrey Pines,etc… If this is checks off their 2nd term sheet promise this will not be good. I am not a troll I have been holding and buying since a week before FDA approval, biggest holding in my piortfolio, but regretfullably so to date.
|
|
|
|
Post by morgieporgie on Jul 27, 2018 23:15:23 GMT -5
Hugely disappointed by lack of transparency here. Tanners group game plan, RLS game plan, not to mention Trepostinil, Torrey Pines,etc… If this is checks off their 2nd term sheet promise this will not be good. I am not a troll I have been holding and buying since a week before FDA approval, biggest holding in my piortfolio, but regretfullably so to date. I guess I'm not the only one? Or maybe that's my other login? Cmon guys, I'm long but something ain't adding up here. Admit it! |
|
|
|
Post by morgieporgie on Jul 27, 2018 23:17:10 GMT -5
Can you tell me what happened to the One Drop deal? How about Torrey Pines? Tell me a bit about Receptor Life Sciences? That's enough for now. Let's feed the troll. One Drop and MannKind currently have an active clinical trial together with the estimated primary completion date set for September 30, 2018. The rest you can look up yourself. Uber of diabetes? Outsulin charcter? |
|
|
|
Post by centralcoastinvestor on Jul 27, 2018 23:21:48 GMT -5
What is really sad to me is the way shorts bash the company and could give 2 shits about a drug that really helps diabetics! Listen, I wanna make money like the next person does but listening to Negative comments only because of money and never giving a shit about patient care is getting old. Afrezza helps people. This is #1. Stock price will adjust soon enough. God Bless you Mr. Mann! Well said. |
|
|
|
Post by barnstormer on Jul 27, 2018 23:41:12 GMT -5
The bottom line is that all longs want both Afrezza and the share price to succeed. It's a wonderful drug and we have hung our hat and our wallets on it. So far we only get a teaspoon of hope toward realizing it's potential to deliver on both. Deals with no up front money show how desparate things are. Tanner? Just another BS agreement that has no teeth. With no skin in the game they could fold their tent and move on with no notice. We can rah, rah all we want but until Mike comes up with a real partner we are SCREWED. You can put lipstick on a pig, but at the end of the day you still have a pig. We all were absolutely sure that the STAT and ADA would make a difference and we have the TV ads we all wanted. If things don't pick up the earnings call (moved up) will be a disaster. You can't keep making deals with companies that aren't willing to anti-up to assure success. So far they are excess baggage. At the rate we are going we will be staring down the barrel of another RS just to hold the NASDAQ listing. Mike Kovacocy where the hell is your next catalyst? So far its's just all hot air.
|
|
|
|
Post by morgieporgie on Jul 27, 2018 23:46:12 GMT -5
The bottom line is that all longs want both Afrezza and the share price to succeed. It's a great drug and we have hung our hat and our wallets on it. So far we only get a teaspoon of hope toward realizing it's potential to deliver on both. Deals with no up front money show how desparate things are. Tanner? Just another BS agreement that has no teeth. With no skin in the game they could fold their tent and move on with no notice. We can rah, rah all we want but until Mike comes up with a real partner we are SCREWED. Well said. |
|
|
|
Post by mytakeonit on Jul 28, 2018 0:14:37 GMT -5
NOT !!! More rice and wine please. Peppy ... more rice and wine please !!!
|
|
|
|
Post by babaoriley on Jul 28, 2018 0:22:45 GMT -5
Hugely disappointed by lack of transparency here. Tanners group game plan, RLS game plan, not to mention Trepostinil, Torrey Pines,etc… If this is checks off their 2nd term sheet promise this will not be good. I am not a troll I have been holding and buying since a week before FDA approval, biggest holding in my piortfolio, but regretfullably so to date. You've been buying since a week before approval and after all this slippage in price MNKD is still the largest holding in your portfolio? Wow, hope you're a young guy. |
|
|
|
Post by mytakeonit on Jul 28, 2018 1:22:47 GMT -5
I'm not a young guy ... but I still thrill some of these well to do ladies that drive by my house when I have to water the yard. But ... that's another story.
For your info baba ... I'm all in on MNKD. That is the only stock in all of my portfolios NOW. I'm not advising anyone else to do the same ... but, I am a believer.
If I am wrong ... heck ... it's only money.
|
|
|
|
Post by plumber7474 on Jul 28, 2018 7:44:22 GMT -5
The bottom line is that all longs want both Afrezza and the share price to succeed. It's a wonderful drug and we have hung our hat and our wallets on it. So far we only get a teaspoon of hope toward realizing it's potential to deliver on both. Deals with no up front money show how desparate things are. Tanner? Just another BS agreement that has no teeth. With no skin in the game they could fold their tent and move on with no notice. We can rah, rah all we want but until Mike comes up with a real partner we are SCREWED. You can put lipstick on a pig, but at the end of the day you still have a pig. We all were absolutely sure that the STAT and ADA would make a difference and we have the TV ads we all wanted. If things don't pick up the earnings call (moved up) will be a disaster. You can't keep making deals with companies that aren't willing to anti-up to assure success. So far they are excess baggage. At the rate we are going we will be staring down the barrel of another RS just to hold the NASDAQ listing. Mike Kovacocy where the hell is your next catalyst? So far its's just all hot air. Well said!! |
|
|
|
Post by joeypotsandpans on Jul 28, 2018 7:45:13 GMT -5
I had a little fun reality yesterday, now I just need Dennis and friends to help me exercise those sold MNKD puts in that synthetic or they can expire worthless with the paired calls ITM, either works for me  , Peppy (you'll be able to appreciate this) the SPX is looking very weak on this retest of the previous highs, I faded into the well publicized GDP report, will continue to do so and add to this equity that has a nice lofty SI expecting the well publicized impending dilution of a stock with a product that is just flat out awesome, guess I am the epitome of the ultimate contrarian at this point and every time our friends chime in on the impending Castagna guidance miss "that the street will not like" as SO reminds us every week along with folks like Kastanes recent capitulation rant, I get visions of Cramer hitting that buy buy buy button...again just a little bit of fun in the dog days of the "hot air" of summer in the wonderful southern Nevada desert lol.: SLD 1,000 MNKD 1.5815 USD IBKRATS JUL 26 12:43:22 BOT 40 SPY Aug03'18 281 PUT 0.71 USD AMEX JUL 26 13:08:37 OptTrader SLD 20 SPY Aug03'18 281 PUT 1.45 USD AMEX JUL 27 09:39:45 SLD 19 SPY Aug03'18 281 PUT 1.45 USD AMEX JUL 27 09:39:45 SLD 1 SPY Aug03'18 281 PUT 1.45 USD AMEX JUL 27 09:39:45 SLD 20 SPY Aug03'18 281 PUT 1.61 USD ISE JUL 27 09:59:15 SLD 10 SPY Aug03'18 281 PUT 1.61 USD ISE JUL 27 09:59:15 SLD 10 SPY Aug03'18 281 PUT 1.61 USD ISE JUL 27 09:59:15 BOT 50 MNKD Sep 1.5 Synthetic 0.045 USD SMART JUL 27 10:48:43 BOT 11 MNKD Sep 1.5 Synthetic 0.05 USD SMART JUL 27 10:48:43 BOT 13 MNKD Sep 1.5 Synthetic 0.05 USD SMART JUL 27 10:48:43 BOT 26 MNKD Sep 1.5 Synthetic 0.04 USD SMART JUL 27 10:48:43 |
|
|
|
Post by morfu on Jul 28, 2018 8:00:45 GMT -5
The bottom line is that all longs want both Afrezza and the share price to succeed. It's a wonderful drug and we have hung our hat and our wallets on it. So far we only get a teaspoon of hope toward realizing it's potential to deliver on both. Deals with no up front money show how desparate things are. Tanner? Just another BS agreement that has no teeth. With no skin in the game they could fold their tent and move on with no notice. We can rah, rah all we want but until Mike comes up with a real partner we are SCREWED. You can put lipstick on a pig, but at the end of the day you still have a pig. We all were absolutely sure that the STAT and ADA would make a difference and we have the TV ads we all wanted. If things don't pick up the earnings call (moved up) will be a disaster. You can't keep making deals with companies that aren't willing to anti-up to assure success. So far they are excess baggage. At the rate we are going we will be staring down the barrel of another RS just to hold the NASDAQ listing. Mike Kovacocy where the hell is your next catalyst? So far its's just all hot air. >> We can rah, rah all we want but until Mike comes up with a real partner we are SCREWED.
I guess other companies would like to be screwed like that! We have a very good and unique product and about 5%growth ... per week! If the trend holds and STAT and ADA's impact is still looming, we easily double the script numbers within a year. Another 100 scripts per week from Bazil, India and that new Collaboration and we are close to make money! You might take some different numbers and end up with 2years until profit, but it is a reality, that we show solid growth over the last months!
What can a partner contribute to that!? Some money to avoid another dilution, but will cost us shared profit in the long run? We've been there and done that! (Actually, I am grateful for Sanofi's about 200millions to get Afrezza started!)
|
|
|
|
Post by lennymnkd on Jul 28, 2018 8:17:41 GMT -5
The bottom line is that all longs want both Afrezza and the share price to succeed. It's a wonderful drug and we have hung our hat and our wallets on it. So far we only get a teaspoon of hope toward realizing it's potential to deliver on both. Deals with no up front money show how desparate things are. Tanner? Just another BS agreement that has no teeth. With no skin in the game they could fold their tent and move on with no notice. We can rah, rah all we want but until Mike comes up with a real partner we are SCREWED. You can put lipstick on a pig, but at the end of the day you still have a pig. We all were absolutely sure that the STAT and ADA would make a difference and we have the TV ads we all wanted. If things don't pick up the earnings call (moved up) will be a disaster. You can't keep making deals with companies that aren't willing to anti-up to assure success. So far they are excess baggage. At the rate we are going we will be staring down the barrel of another RS just to hold the NASDAQ listing. Mike Kovacocy where the hell is your next catalyst? So far its's just all hot air. What make you think Mikes not putting this all together for a “real partner “ |
|
, Peppy (you'll be able to appreciate this) the SPX is looking very weak on this retest of the previous highs, I faded into the well publicized GDP report, will continue to do so and add to this equity that has a nice lofty SI expecting the well publicized impending dilution of a stock with a product that is just flat out awesome, guess I am the epitome of the ultimate contrarian at this point and every time our friends chime in on the impending Castagna guidance miss "that the street will not like" as SO reminds us every week along with folks like Kastanes recent capitulation rant, I get visions of Cramer hitting that buy buy buy button...again just a little bit of fun in the dog days of the "hot air" of summer in the wonderful southern Nevada desert lol.: